Coronary Angioplasty versus Fibrinolytic Therapy in Acute Myocardial Infarction [2] (multiple letters)

New England Journal of Medicine

Volumn 349, Issue 22, 2003, Pages 2167-2169

  Channer, Kevin S ^a   Armstrong, Paul W ^b   Antman, Elliott M ^c   Zaman, Azfar G ^d   Andersen, Henning R ^e   Nielsen, Torsten T ^e  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d FREEMAN HOSPITAL   (United Kingdom)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; PYRIDINE DERIVATIVE; THIENOPYRIDINE DERIVATIVE; HEPARIN;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CORONARY ARTERY DILATATION; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; RANDOMIZATION; REDUCTION; ST SEGMENT; STROKE; SURVIVAL RATE; MYOCARDIAL INFARCTION; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; CONTRAINDICATIONS; INCIDENCE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MYOCARDIAL INFARCTION; RECURRENCE; SURVIVAL RATE; ANGIOPLASTY, BALLOON, CORONARY; PLATELET AGGREGATION INHIBITORS; PYRIDINES; HEPARIN; INCIDENCE; STROKE;

EID: 0344851785     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200311273492217     Document Type: Letter

References (0)